Lipopolysaccharide-Binding Protein Plasma Levels and Liver TNF-Alpha Gene Expression in Obese Patients: Evidence for the Potential Role of Endotoxin in the Pathogenesis of Non-Alcoholic Steatohepatitis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thurman RG. II. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 1998; 275 (4 Pt 1): G605–G611.
Bode C, Bode JC. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Alcohol Clin Exp Res 2005; 29 (Suppl 11): 166S–171S.
Yang SQ, Lin HZ, Lane MD et al. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 1997; 94: 2557–62.
Li Z, Yang S, Lin H et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003; 37: 343–50.
Wigg AJ, Roberts-Thomson IC, Dymock RB et al. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001; 48: 206–11.
Sax HC, Talamini MA, Brackett K et al. Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels. Surgery 1986; 100: 697–704.
Loguercio C, De Simone T, D’Auria MV et al. Nonalcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver. Dig Liver Dis 2004; 36: 398–405.
Ulevitch RJ, Tobias PS. Interactions of bacterial lipopolysaccharides with serum proteins. Prog Clin Biol Res 1988; 272: 309–18.
Anker SD, Egerer KR, Volk HD et al. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 1997; 79: 1426–30.
Lequier LL, Nikaidoh H, Leonard SR et al. Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest 2000; 117: 1706–12.
Albillos A, de la Hera A, Gonzalez M et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003; 37: 208–17.
Tobias PS, Soldau K, Ulevitch RJ. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986; 164: 777–93.
Geller DA, Kispert PH, Su GL et al. Induction of hepatocyte lipopolysaccharide binding protein in models of sepsis and the acute-phase response. Arch Surg 1993; 128: 22–7.
Calvano SE, Thompson WA, Marra MN et al. Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis. Arch Surg 1994; 129: 220–6.
Schumann RR. Mechanisms of transcriptional activation of lipopolysaccharide binding protein (LBP). Prog Clin Biol Res 1995; 392: 297–304.
Brunt EM, Janney CG, Di Bisceglie AM et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467–74.
Brunt EM, Neuschwander-Tetri BA, Oliver D et al. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol 2004; 35: 1070–82.
Roslansky PF, Novitsky TJ. Sensitivity of Limulus amebocyte lysate (LAL) to LAL-reactive glucans. J Clin Microbiol 1991; 29: 2477–83.
Hurley JC. Endotoxemia: methods of detection and clinical correlates. Clin Microbiol Rev 1995; 8: 268–92.
Novitsky TJ. Limitations of the Limulus amebocyte lysate test in demonstrating circulating lipopolysac-charides. Ann NY Acad Sci 1998; 851: 416–21.
Munford RS. Detoxifying endotoxin: time, place and person. J Endotoxin Res 2005; 11: 69–84.
Schumann RR, Leong SR, Flaggs GW et al. Structure and function of lipopolysaccharide binding protein. Science 1990; 249 (4975): 1429–31.
Zweigner J, Schumann RR, Weber JR. The role of lipopolysaccharide-binding protein in modulating the innate immune response. Microbes Infect 2006; 8: 946–52.
Hiki N, Berger D, Mimura Y et al. Release of endotoxin-binding proteins during major elective surgery: role of soluble CD14 in phagocytic activation. World J Surg 2000; 24: 499–506.
Wiezer MJ, Meijer C, Sietses C et al. Bactericidal/permeability-increasing protein preserves leukocyte functions after major liver resection. Ann Surg 2000; 232: 208–15.
Brun P, Castagliuolo I, Leo VD et al. Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2006; 292: G518–25.
Chitturi S, Farrell GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001; 21: 27–41.
Kugelmas M, Hill DB, Vivian B et al. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003; 38: 413–9.
Crespo J, Cayon A, Fernandez-Gil P et al. Gene expression of tumor necrosis factor alpha and TNFreceptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology 2001; 34: 1158–63.
Katsuki A, Sumida Y, Murashima S et al. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998; 83: 859–62.
Tsigos C, Kyrou I, Chala E et al. Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism 1999; 48: 1332–5.
Wright SD, Tobias PS, Ulevitch RJ et al. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J Exp Med 1989; 170: 1231–41.
Viriyakosol S, Tobias PS, Kitchens RL et al. MD-2 binds to bacterial lipopolysaccharide. J Biol Chem 2001; 276: 38044–51.
Thomas CJ, Kapoor M, Sharma S et al. Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response. FEBS Lett 2002; 531: 184–8.
Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995; 13: 437–57.
Gioannini TL, Teghanemt A, Zarember KA et al. Regulation of interactions of endotoxin with host cells. J Endotoxin Res 2003; 9: 401–8.